Variant report
Variant | nsv821650 |
---|---|
Chromosome Location | chr6:79002204-79095287 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:78966571..78967392-chr6:79036188..79036778,2 | MCF-7 | breast: | |
2 | chr6:79079721..79080316-chr6:79223325..79224142,2 | MCF-7 | breast: | |
3 | chr6:79037479..79040377-chr6:79044089..79045864,2 | K562 | blood: | |
4 | chr6:79037479..79040377-chr6:79044089..79045864,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs151208733 | chr6:79010469-79010470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528148835 | chr6:79010476-79010477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551041257 | chr6:79010517-79010518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139187167 | chr6:79010521-79010522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75684724 | chr6:79010522-79010523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550599254 | chr6:79010577-79010578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567407166 | chr6:79010605-79010606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536561435 | chr6:79010644-79010645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550397677 | chr6:79010650-79010651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546788917 | chr6:79010656-79010657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371696927 | chr6:79010676-79010677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566649003 | chr6:79010692-79010693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs199672970 | chr6:79010742-79010743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs370270612 | chr6:79010744-79010745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573899335 | chr6:79010799-79010800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529830112 | chr6:79010800-79010801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538867988 | chr6:79010913-79010914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559081128 | chr6:79010994-79010995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181846290 | chr6:79011014-79011015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112999464 | chr6:79011021-79011022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149965548 | chr6:79011026-79011027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs186086109 | chr6:79011103-79011104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9361392 | chr6:79011176-79011177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78940213 | chr6:79011271-79011272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190938574 | chr6:79011310-79011311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77475272 | chr6:79011327-79011328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs200590054 | chr6:79011376-79011377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73464221 | chr6:79011465-79011466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182449772 | chr6:79011502-79011503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs546028871 | chr6:79011515-79011516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564636933 | chr6:79011517-79011518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs386702939 | chr6:79011552-79011553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375226676 | chr6:79011555-79011556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs578137435 | chr6:79011559-79011560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188317377 | chr6:79011568-79011569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs141979984 | chr6:79011622-79011623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368564812 | chr6:79011628-79011629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190074532 | chr6:79011669-79011670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529685033 | chr6:79011677-79011678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546901080 | chr6:79011735-79011736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs566810042 | chr6:79011741-79011742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs538831321 | chr6:79011750-79011751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs371503872 | chr6:79011762-79011763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs201649197 | chr6:79011769-79011770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs28374826 | chr6:79011795-79011796 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs569211883 | chr6:79011835-79011836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538354352 | chr6:79011857-79011858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs183039473 | chr6:79011968-79011969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2198322 | chr6:79011985-79011986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368889595 | chr6:79012248-79012249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Cancer | 21272361 | CNVD |
Medulloblastoma | 21163964 | CNVD |
Bipolar disorder | 19214233 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:79010400-79011000 | Enhancers | HMEC | breast |
2 | chr6:79011000-79012000 | Weak transcription | HMEC | breast |
3 | chr6:79012200-79012400 | Enhancers | HMEC | breast |
4 | chr6:79017800-79018000 | ZNF genes & repeats | Aorta | Aorta |
5 | chr6:79018000-79020400 | Weak transcription | Aorta | Aorta |
6 | chr6:79031400-79033200 | Enhancers | Liver | Liver |
7 | chr6:79053800-79054200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:79054000-79057200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr6:79054200-79054600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
10 | chr6:79054600-79056600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr6:79054800-79056200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr6:79054800-79056800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr6:79055200-79056000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr6:79055200-79056600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr6:79055600-79056000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
16 | chr6:79055800-79056200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr6:79056600-79057600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
18 | chr6:79057200-79059600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
19 | chr6:79059600-79060400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
20 | chr6:79059800-79060200 | Enhancers | H1 Cell Line | embryonic stem cell |
21 | chr6:79080200-79080800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr6:79080800-79089000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr6:79089000-79090200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
24 | chr6:79090200-79091000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
25 | chr6:79091000-79091600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
26 | chr6:79091600-79092000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
27 | chr6:79092000-79095800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |